维普期刊资源整合服务平台（V6.5）

122篇 您的检索式：作者名="Sniderman AD"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Should we use apoB for risk assessment and as a target for treatment显示文摘	Brown WV Myers GL Sniderman AD	2010	J Clin Lipidol2010，4，3：	1
2	Aproposal to redefine familial combined hyperlipidaemia-third workshop on FCHL held in Barcelona from 3 to 5 may 2001, during the scientific sessions of the European Society for Clinical Investigation显示文摘	Sniderman AD Castro Cabezas M Ribalta J	2002	Eur J Clin Invest2002，32，2：	1
3	Apelipeproteins versus lipids as indices of coronary risk and as targets for statin treatment 显示文摘	Sniderman AD Furberg CD Keech A	2003	Lancet2003，361，9359：	1
4	Enhanced revascularization of the ischemic limb by angiogenic therapy显示文摘	Pu LQ Sniderman AD Brassard R	1993	Circulation1993，88，1：	1
5	Hypertriglyceridemic hyperapob:the unappreciated at herogenic dys1ipoproteinemia in type 2 diabetes mellitus显示文摘	Sniderman AD Scantlebury T Cianflone K	2001	Ann Intern Med2001，135，6：	1
6	A meta-analysis of low-density lipoprotein cholesterol,non-high-density lipoprotein cholesterol,and apolipoprotein B as markers of cardiovascular risk显示文摘	Sniderman AD Williams K Contois JH	2011	Circ Cardiovasc Qual Outcomes2011，4，3：	1
7	Aylation stimulating protein (ASP), an adipocyte autocrine: new directions显示文摘	Cianflone K Maslowska M Sniderman AD	1999	Semin Cell Dev Biol1999，10，：	1
8	Acylation stimulating protein( ASP), an adipocyte autocrine : new directions 显示文摘	Cianflone K Maslowska M Sniderman AD	1999	Semin Cell Dev Biol1999，10，：	1
9	Substrate delivery as a de terminant of hepatic apoB secretion显示文摘	Sniderman AD Cianflone K	1993	Arterioscler Thromb Vasc Bio11993，13，62：	1
10	Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula显示文摘	Sniderman AD Blank D Zakarian R	2003	Clin Biochem2003，36，：	1
11	Dose low-density lipoprotein size add to atherogenie particle number in predicting the risk of fatal myocardial infarction 显示文摘	JUNGNER I SNIDERMAN AD FURBERG C	2006	Am J Cardiol2006，97，：	1
12	Discordance analysis of apo-lipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study显示文摘	Sniderman AD Islam S Yusuf S	2012	Atherosclerosis2012，225，2：	1
13	Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis显示文摘	Sniderman AD Wolfsnn C Teng B	1982	Ann Intern Med1982，97，6：	1
14	The adipsin-ASP pathway and regulation of adipocyte function 显示文摘	Sniderman AD Cianflone K	1994	Ann Med1994，26，6：	1
15	Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study显示文摘	Sniderman AD Islam S Yusuf S	2012	Atherosclerosis2012，225，2：	1
16	Counterpoint To (measure apo) B or not to (measure apo)B:a critique of modem medical decision-making显示文摘	Sniderman AD	1997	Clin Chem1997，43，：	1
17	ASP stimulates glucose transport in cultured human adipocytes显示文摘	Maslowska M Sniderman AD Germinario R	1997	Int J Obes1997，21，4：	1
18	Putting lower-density lipoproteins at a center stage in atherogenesis显示文摘	Sniderman AD Pedersen T Kjekshus J	1997	Am J Cardiol1997，79，：	1
19	Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment显示文摘	Sniderman AD Furberg CD Keech A Roeters Van Lennep JE Frohlich J Jungner I	2003	Guget2003，361，3：	1
20	Putting low-density lipoproteins at a center stage in atherogenesis显示文摘	Sniderman AD Pedersen T Kjekshus J	1997	Am J Cardiol1997，79，1：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示